Giananthony Rizzo[email protected]Nuclear MedicineIs the U.S. due for a shortage of SPECT tracers? Part 2In the second part of our series on the coming shortage of SPECT radiopharmaceuticals, Giananthony Rizzo of Decision Resources Group examines other factors in the U.S. healthcare industry that could affect isotope prices in the future.November 17, 2016Nuclear MedicineIs the U.S. due for a shortage of SPECT tracers? Part 1A perfect storm is brewing in the global SPECT market that could see the prices of radiopharmaceuticals skyrocket over the next five years. A number of factors are coalescing that could lead to a shortage of SPECT tracers for years to come, according to this article by Giananthony Rizzo of Decision Resources Group.November 16, 2016Page 1 of 1Top StoriesPractice ManagementNew MR safety codes provide additional reimbursement for radiologistsIn a new column, Erin Stephens of Healthcare Administrative Partners reviews the new CPT code changes for MR safety services.CTCT, MRI reveal hidden brain changes linked to increased fall riskWomens ImagingImaging societies, experts react to U.S. Supreme Court's ruling on Braidwood caseMRIDeep learning plus MRI predicts likelihood of postpartum hemorrhageWomens ImagingPersonal tragedies spur unity behind bill for diagnostic breast care
